These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 10986336)

  • 1. Astressin, a corticotropin releasing factor antagonist, reverses the anxiogenic effects of urocortin when administered into the basolateral amygdala.
    Sajdyk TJ; Gehlert DR
    Brain Res; 2000 Sep; 877(2):226-34. PubMed ID: 10986336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of corticotropin-releasing factor and urocortin within the basolateral amygdala of rats in anxiety and panic responses.
    Sajdyk TJ; Schober DA; Gehlert DR; Shekhar A
    Behav Brain Res; 1999 Apr; 100(1-2):207-15. PubMed ID: 10212068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed satiety-like actions and altered feeding microstructure by a selective type 2 corticotropin-releasing factor agonist in rats: intra-hypothalamic urocortin 3 administration reduces food intake by prolonging the post-meal interval.
    Fekete EM; Inoue K; Zhao Y; Rivier JE; Vale WW; Szücs A; Koob GF; Zorrilla EP
    Neuropsychopharmacology; 2007 May; 32(5):1052-68. PubMed ID: 17019404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeated stimulation of CRF receptors in the BNST of rats selectively induces social but not panic-like anxiety.
    Lee Y; Fitz S; Johnson PL; Shekhar A
    Neuropsychopharmacology; 2008 Oct; 33(11):2586-94. PubMed ID: 18288095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticotrophin releasing factor-induced synaptic plasticity in the amygdala translates stress into emotional disorders.
    Rainnie DG; Bergeron R; Sajdyk TJ; Patil M; Gehlert DR; Shekhar A
    J Neurosci; 2004 Apr; 24(14):3471-9. PubMed ID: 15071094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of an agonist, urocortin, and an antagonist, astressin, as radioligands for characterization of corticotropin-releasing factor receptors.
    Perrin MH; Sutton SW; Cervini LA; Rivier JE; Vale WW
    J Pharmacol Exp Ther; 1999 Feb; 288(2):729-34. PubMed ID: 9918582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Injections of urocortin 1 into the basolateral amygdala induce anxiety-like behavior and c-Fos expression in brainstem serotonergic neurons.
    Spiga F; Lightman SL; Shekhar A; Lowry CA
    Neuroscience; 2006; 138(4):1265-76. PubMed ID: 16488545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II's role in sodium lactate-induced panic-like responses in rats with repeated urocortin 1 injections into the basolateral amygdala: amygdalar angiotensin receptors and panic.
    Johnson PL; Sajdyk TJ; Fitz SD; Hale MW; Lowry CA; Hay-Schmidt A; Shekhar A
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jul; 44():248-56. PubMed ID: 23523745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time-dependent induction of anxiogenic-like effects after central infusion of urocortin or corticotropin-releasing factor in the rat.
    Spina MG; Merlo-Pich E; Akwa Y; Balducci C; Basso AM; Zorrilla EP; Britton KT; Rivier J; Vale WW; Koob GF
    Psychopharmacology (Berl); 2002 Mar; 160(2):113-21. PubMed ID: 11875628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of neuropeptide Y in the amygdala on corticotropin-releasing factor receptor-mediated behavioral stress responses in the rat.
    Sajdyk TJ; Fitz SD; Shekhar A
    Stress; 2006 Mar; 9(1):21-8. PubMed ID: 16753930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The activation and blockage of CRF type 2 receptors of the medial amygdala alter elevated T-maze inhibitory avoidance, an anxiety-related response.
    Alves SW; Portela NC; Silva MS; Céspedes IC; Bittencourt JC; Viana MB
    Behav Brain Res; 2016 May; 305():191-7. PubMed ID: 26965566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From anxiety to autism: spectrum of abnormal social behaviors modeled by progressive disruption of inhibitory neuronal function in the basolateral amygdala in Wistar rats.
    Truitt WA; Sajdyk TJ; Dietrich AD; Oberlin B; McDougle CJ; Shekhar A
    Psychopharmacology (Berl); 2007 Mar; 191(1):107-18. PubMed ID: 17277936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of Ca2+ influx by corticotropin-releasing factor (CRF) family of peptides via CRF receptors in rat pancreatic beta-cells.
    Kageyama K; Kimura R; Suga S; Ogawa Y; Suda T; Wakui M
    Peptides; 2006 Jul; 27(7):1814-9. PubMed ID: 16513211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stress and central Urocortin increase anxiety-like behavior in the social interaction test via the CRF1 receptor.
    Gehlert DR; Shekhar A; Morin SM; Hipskind PA; Zink C; Gackenheimer SL; Shaw J; Fitz SD; Sajdyk TJ
    Eur J Pharmacol; 2005 Feb; 509(2-3):145-53. PubMed ID: 15733549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticotropin-releasing factor (CRF) antagonist [D-Phe12,Nle21,38,C alpha MeLeu37]CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in rats.
    Rodríguez de Fonseca F; Rubio P; Menzaghi F; Merlo-Pich E; Rivier J; Koob GF; Navarro M
    J Pharmacol Exp Ther; 1996 Jan; 276(1):56-64. PubMed ID: 8558457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local repeated corticotropin-releasing factor infusion exacerbates anxiety- and fear-related behavior: differential involvement of the basolateral amygdala and medial prefrontal cortex.
    Bijlsma EY; van Leeuwen ML; Westphal KG; Olivier B; Groenink L
    Neuroscience; 2011 Jan; 173():82-92. PubMed ID: 21093544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interaction of Urocortin II and Urocortin III with amygdalar and hypothalamic cotricotropin-releasing factor (CRF)--reflections on the regulation of the hypothalamic-pituitary-adrenal (HPA) axis.
    Bagosi Z; Csabafi K; Palotai M; Jászberényi M; Földesi I; Gardi J; Szabó G; Telegdy G
    Neuropeptides; 2013 Oct; 47(5):333-8. PubMed ID: 23932308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium lactate elicits anxiety in rats after repeated GABA receptor blockade in the basolateral amygdala.
    Sajdyk TJ; Shekhar A
    Eur J Pharmacol; 2000 Apr; 394(2-3):265-73. PubMed ID: 10771292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticotropin-releasing factor (CRF) sensitization of ethanol withdrawal-induced anxiety-like behavior is brain site specific and mediated by CRF-1 receptors: relation to stress-induced sensitization.
    Huang MM; Overstreet DH; Knapp DJ; Angel R; Wills TA; Navarro M; Rivier J; Vale W; Breese GR
    J Pharmacol Exp Ther; 2010 Jan; 332(1):298-307. PubMed ID: 19843974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microinjection of urocortin 2 into the dorsal raphe nucleus activates serotonergic neurons and increases extracellular serotonin in the basolateral amygdala.
    Amat J; Tamblyn JP; Paul ED; Bland ST; Amat P; Foster AC; Watkins LR; Maier SF
    Neuroscience; 2004; 129(3):509-19. PubMed ID: 15541873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.